Cyprotex (CRX)

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

5.38p
   
  • Change Today:
    -0.13p
  • 52 Week High: 6.50p
  • 52 Week Low: 2.88p
  • Currency: UK Pounds
  • Shares Issued: 223.69m
  • Volume: 19,299
  • Market Cap: £12.02m
  • RiskGrade: 284

Regulatory News

Product Launch 03-May-2012 07:00 RNS
Final Results 22-Mar-2012 07:00 RNS
Pre-Closed Trading Update 12-Jan-2012 07:00 RNS
Sygnature Discovery and Cyprotex Extend Alliance 16-Dec-2011 07:00 RNS
Product Upgrade 09-Nov-2011 07:00 RNS
Expansion of US Facility 07-Nov-2011 07:00 RNS
Board Change 29-Sep-2011 07:00 RNS
Half Yearly Report 25-Aug-2011 07:00 RNS
Re Agreement 08-Jul-2011 07:00 RNS
AGM Statement 30-Jun-2011 07:00 RNS
Final Results 23-Mar-2011 07:00 RNS
Revised date for Results 11-Mar-2011 12:34 RNS
Notice of Results 01-Mar-2011 12:50 RNS
Trading Statement 24-Dec-2010 07:00 RNS
Director/PDMR Shareholding 08-Nov-2010 16:53 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cyprotex Market Data

Currency UK Pounds
Share Price 5.38p
Change Today -0.13p
% Change -2.27 %
52 Week High 6.50p
52 Week Low 2.88p
Volume 19,299
Shares Issued 223.69m
Market Cap £12.02m
RiskGrade 284

Cyprotex Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
6.11% above the market average6.11% above the market average6.11% above the market average6.11% above the market average6.11% above the market average
82.98% above the sector average82.98% above the sector average82.98% above the sector average82.98% above the sector average82.98% above the sector average
Price Trend
93.94% above the market average93.94% above the market average93.94% above the market average93.94% above the market average93.94% above the market average
82.14% above the sector average82.14% above the sector average82.14% above the sector average82.14% above the sector average82.14% above the sector average
Income Not Available
Growth
84.12% above the market average84.12% above the market average84.12% above the market average84.12% above the market average84.12% above the market average
87.76% above the sector average87.76% above the sector average87.76% above the sector average87.76% above the sector average87.76% above the sector average

Cyprotex Dividends

No dividends found

Trades for 31-May-2012

Time Volume / Share Price
09:57 9,299 @ 5.35p
08:07 10,000 @ 5.25p

Cyprotex Key Personnel

CEO Anthony Baxter
CFO John Dootson

Top of Page